Home > Research > Current Projects > IMPROVE PRETERM

IMPROVE PRETERM: Improving Lifelong Health for Babies Born Very Preterm

IMPROVE PRETERM is a four-year European research project working to improve the lifelong health and development of children and adults born very preterm – before 32 weeks of pregnancy.

 

Thanks to advances in neonatal care, more very preterm babies survive today than ever before. But survival is only the beginning. Many children and adults born very preterm face long-term challenges affecting learning, physical health, mental health, and quality of life. Families and healthcare providers often lack clear, evidence-based guidance on what care and follow-up work best over time.

 

IMPROVE PRETERM brings together researchers, clinicians, families, and advocates from across Europe to close these gaps. The project focuses on generating better evidence, developing practical tools, and strengthening follow-up care – so children born very preterm can not only survive, but thrive.

 

Background

Illustration showing families, healthcare professionals, and a child, representing lifelong care and development after very preterm birth

Very preterm birth is a major public health issue worldwide. Children born too soon are at higher risk of developmental delays, cerebral palsy, respiratory illness, learning difficulties, and mental health conditions that can persist into adulthood.

 

While neonatal care has improved survival, long-term outcomes have not improved at the same pace. One key reason is the lack of strong, consistent evidence about which treatments, follow-up programs, and preventive strategies work best across the life course.

 

Research in this area faces real challenges:

  • Randomized clinical trials are often difficult or unethical to run in very preterm populations.
  • Observational data exists, but is hard to compare across countries and healthcare systems.
  • Long-term outcomes that matter to families are not always measured consistently.
  • Follow-up care varies widely, leading to unequal support for children and families.

 

IMPROVE PRETERM addresses these gaps by combining large-scale data, modern research methods, and family perspectives to generate clearer, more useful evidence for real-world care.

 

Project Structure

Infographic showing the six workstreams of the IMPROVE PRETERM project, from stakeholder engagement to management and ethics

IMPROVE PRETERM is a large international collaboration involving 20 partner organizations from 13 countries. The project runs from January 2025 to December 2028 and is funded by the European Union’s Horizon Europe Research and Innovation program.

 

The work is organized into six interconnected workstreams, covering:

 

  • Stakeholder and family involvement and communication
  • Comparative effectiveness research on key interventions
  • Development of a life-course research framework
  • Creation of a new parent-reported follow-up tool
  • Expansion and long-term sustainability of a European data platform
  • Project management, ethics, and governance

 

This structure ensures that scientific research, lived experience, data infrastructure, and communication all work together toward the same goal: better lifelong outcomes for people born very preterm.

 

Aims and Objectives

Infographic showing the five core goals of the IMPROVE PRETERM project focused on lifelong health after very preterm birth

IMPROVE PRETERM has five core objectives:

 

  • Improve evidence on what works: Identify which treatments, follow-up programs, and preventive strategies are most effective for children born very preterm.
  • Support lifelong follow-up and care: Focus on health and development beyond infancy, recognizing that challenges and needs evolve over time.
  • Develop practical tools for families and clinicians: Create accessible, evidence-based tools such as a new parent-reported questionnaire to track child development at school age.
  • Strengthen research methods and data systems: Combine observational studies and trial data using advanced, privacy-preserving methods to improve research quality.
  • Center families in research and decision-making: Ensure that parents and adults born very preterm help shape research priorities, outcomes, and communication.

 

Together, these aims support more informed care, fairer follow-up systems, and better long-term health for very preterm individuals.

 

GFCNI’s Role in the Project

Parents caring for and bonding with newborn babies, including scenes from neonatal intensive care

GFCNI leads stakeholder and family involvement, communication, and dissemination within IMPROVE PRETERM.

 

GFCNI ensures that:

  • Families’ lived experiences inform research priorities and tools
  • Parents and adults born very preterm are actively involved through advisory boards
  • Research findings are communicated clearly, responsibly, and accessibly
  • Project results reach families, healthcare professionals, and policymakers

 

By bridging science and lived experience, GFCNI helps ensure that IMPROVE PRETERM delivers outcomes that are meaningful, ethical, and relevant to real life.

 

Project Teams

In IMPROVE PRETERM, GFCNI leads stakeholder and family involvement, communication, and dissemination activities. GFCNI ensures that families’ lived experiences help shape research priorities, tools, and outcomes, and that project findings are shared in clear, accessible language with families, healthcare professionals, and policymakers. By connecting science with real-life experiences, GFCNI helps ensure that research leads to meaningful, family-centered improvements in care.

 

  • Nicole Thiele, Vice Chair of the Executive Board
  • Teresa Primavesi-Poggio, Head of Policy and Advocacy
  • Ruth Kemper, Project Manager
  • Dr. Annika Brunck, Senior Communications Manager

 

For further information, please contact: research(at)gfcni.org

IMPROVE PRETERM brings together a multidisciplinary consortium of leading institutions, each contributing unique expertise:

 

  • INSERM (France) – Project coordination; expertise in epidemiology, biostatistics, and comparative effectiveness research

     

  • University of Oulu (Finland) – Research on perinatal and neonatal interventions using Nordic register data

     

  • University of Leicester (UK) – Development and validation of the PARCA-5/7 parent-reported follow-up tool

     

  • Norwegian University of Science and Technology – NTNU (Norway) – Research on follow-up and early intervention programs

     

  • University Hospital Würzburg (Germany) – Clinical trials and developmental pediatrics; German Neonatal Network data

     

  • Institute of Public Health, University of Porto – ISPUP (Portugal) – Public health research and qualitative studies

     

  • University of Oxford (UK) – Health economics and policy analysis

     

  • Karolinska Institutet (Sweden) – Pediatric neurology, psychology, and Swedish neonatal register data

     

  • University of Copenhagen (Denmark) – Life-course epidemiology and register-based research

     

  • University Hospital Antwerp – UZA (Belgium) – Neonatal care, follow-up, and family-centered care

     

  • Eugenio Medea Scientific Institute – MEDEA (Italy) – Follow-up research, ethics, and qualitative studies

     

  • University of Tartu (Estonia) – Neonatology, child psychology, and cohort data

     

  • Varha Wellbeing Services County (Finland) – Neonatal follow-up and regional healthcare data

     

  • University of Warwick (UK) – Research on adult outcomes after very preterm birth

     

  • Poznan University of Medical Sciences – PUMS (Poland) – Neonatal care, clinical trials, and infectious disease research

     

  • INESC TEC (Portugal) – Software engineering, artificial intelligence, and data analysis tools

     

  • Epigeny (France) – Secure, privacy-preserving data platforms and open-source research software

     

  • INSERM Transfert (France) – Project management and innovation support

     

  • University of Zurich (Switzerland) – Associated partner contributing neonatal and follow-up expertise

     

Together, this team combines scientific excellence, clinical expertise, technical innovation, and lived experience to improve care for very preterm individuals across Europe.

The Parent & Patient Advisory Board (PPAB) brings together parents of children born very preterm and adults who were themselves born very preterm.

 

The PPAB plays a central role in IMPROVE PRETERM by providing lived-experience perspectives throughout the project. Members advise researchers on which outcomes matter most to families, help shape research tools and communication, and offer feedback to ensure that project activities remain respectful, relevant, and grounded in real-life needs. Through the PPAB, families are partners in research – not just subjects of it.

 

Members of the PPAB are:

 

  • Vilni Verner Holst Bloch, “Prematurforeningen” (Norway)

     

  • Elzbieta Brzozowska, “Koalicja dla wcześniaka Fundacja” (Poland)

     

  • Adriana Guerreiro, “Nascer Prematuro” (Portugal)

     

  • Dina Hediger, “Frühchen & Neokinder Schweiz” (Switzerland)

     

  • Maria Hitzschke, Bundesverband “Das frühgeborene Kind e.V.” (Germany)

     

  • Lauren Ingledow, “Adult Preemie Advocacy Network” (United Kingdom)

     

  • Kristel Kuuk, “MTÜ Enneaegsed lapsed” (Estonia)

     

  • Mirva Rontti, “Kevyt” (Finland)

Learn More About IMPROVE PRETERM

Visit the IMPROVE PRETERM project website for more information about the research

IMPROVE PRETERM has its own project website with in-depth information on the research, partners, and results as the project progresses. If you’d like to explore the project in more detail, you can visit the official IMPROVE PRETERM website.

 

Transparency

European Union flag with text stating that the IMPROVE PRETERM project is funded by the European Union

IMPROVE PRETERM has received funding from the European Union’s Horizon Europe Research and Innovation program under grant agreement 101156325. 

 

© 2025 GFCNI. All Rights Reserved.